These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7009942)

  • 1. Effect of captopril, a converting enzyme inhibitor on renal vascular resistance in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Aug; 30(4):515-9. PubMed ID: 7009942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.
    Wong PC; Zimmerman BG
    J Pharmacol Exp Ther; 1980 Oct; 215(1):104-9. PubMed ID: 7005423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamic effects of captopril in anesthetized sodium-restricted dogs. Relative contributions of prostaglandin stimulation and suppressed angiotensin activity.
    Carmines PK; Rosivall L; Till MF; Navar LG
    Ren Physiol; 1983; 6(6):281-7. PubMed ID: 6359304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of [Sar1, Ala8]angiotensin II on renal vascular resistance.
    Satoh S; Zimmerman BG
    Am J Physiol; 1975 Sep; 229(3):640-5. PubMed ID: 1211457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of captopril on the renal hemodynamics during aprotinin infusion in anesthetized dogs.
    Mizumura Y; Matsumoto M; Nishino A; Takata M; Iida H; Sugimoto T
    Ren Physiol; 1984; 7(5):299-303. PubMed ID: 6207570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of role of sympathetic and renin-angiotensin systems in Goldblatt hypertension with urapidil and captopril.
    Zimmerman BG
    J Hypertens; 1984 Oct; 2(5):485-91. PubMed ID: 6397539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of renal vasodilator effect of captopril on prevailing plasma renin level in the dog: influence of DOCA-salt treatment.
    Wong PC; Zimmerman BG
    Clin Sci (Lond); 1982 Oct; 63(4):355-60. PubMed ID: 7049508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive effect of captopril, an angiotensin converting enzyme inhibitor in pentobarbital anesthetized dogs.
    Satoh S; Fujisawa S; Tanaka R; Nakai K
    Jpn J Pharmacol; 1980 Feb; 30(1):112-5. PubMed ID: 6249947
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.
    Jandhyala BS; Nandiwada P; Buckley JP; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):429-46. PubMed ID: 228363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiotensin-converting enzyme by SQ 14,225 in anesthetized dogs: hemodynamic and renal vascular effects.
    Murthy VS; Waldron TL; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jan; 157(1):121-4. PubMed ID: 202968
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril.
    Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y
    Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal effect of meclofenamate in presence and absence of superfusion bioassay.
    Satoh S; Zimmerman BG
    Am J Physiol; 1976 Mar; 230(3):711-4. PubMed ID: 1266974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release.
    Sugawara S; Zimmerman BG
    Clin Exp Hypertens (1978); 1978; 1(1):11-24. PubMed ID: 755643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma renin activity and hypotensive effect of captopril in dogs.
    Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs.
    Navar LG; Champion WJ; Thomas CE
    Circ Res; 1986 Jun; 58(6):874-81. PubMed ID: 3013463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.